Ilixadencel – an Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration

Intratumoral administration of an immune primer is a therapeutic vaccine strategy aimed to trigger dendritic cell (DC)-mediated cross-presentation of cell-associated tumor antigens to cytotoxic CD8(+) T cells without the need for tumor antigen characterization. The prevailing view is that these cros...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlsson-Parra, Alex, Kovacka, Juliana, Heimann, Emilia, Jorvid, Margareth, Zeilemaker, Sijme, Longhurst, Sharon, Suenaert, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Expert Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002422/
https://www.ncbi.nlm.nih.gov/pubmed/29904904
http://dx.doi.org/10.1007/s11095-018-2438-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002422/
https://www.ncbi.nlm.nih.gov/pubmed/29904904
http://dx.doi.org/10.1007/s11095-018-2438-x

Ejemplares similares